FIGS (NYSE:FIGS – Free Report) had its target price boosted by BTIG Research from $20.00 to $22.00 in a research note issued to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.
Several other brokerages have also weighed in on FIGS. Morgan Stanley lifted their price objective on FIGS from $8.00 to $15.00 and gave the stock an “equal weight” rating in a report on Monday, April 13th. KeyCorp increased their target price on shares of FIGS from $19.00 to $20.00 and gave the stock an “overweight” rating in a research report on Friday. Weiss Ratings downgraded shares of FIGS from a “hold (c+)” rating to a “hold (c)” rating in a research note on Wednesday, May 13th. Barclays boosted their price target on shares of FIGS from $17.00 to $20.00 and gave the company an “overweight” rating in a research report on Friday. Finally, Zacks Research downgraded shares of FIGS from a “strong-buy” rating to a “hold” rating in a report on Friday, May 8th. Six equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $18.71.
Get Our Latest Analysis on FIGS
FIGS Trading Up 26.4%
FIGS (NYSE:FIGS – Get Free Report) last released its earnings results on Thursday, May 7th. The company reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.02. FIGS had a return on equity of 12.65% and a net margin of 8.72%.The business had revenue of $159.90 million during the quarter, compared to the consensus estimate of $153.15 million. The firm’s quarterly revenue was up 28.0% compared to the same quarter last year. Research analysts predict that FIGS will post 0.26 earnings per share for the current year.
Institutional Investors Weigh In On FIGS
Several hedge funds and other institutional investors have recently modified their holdings of FIGS. Elevated Capital Advisors LLC bought a new position in shares of FIGS in the fourth quarter valued at approximately $45,000. Kemnay Advisory Services Inc. bought a new stake in FIGS during the 4th quarter worth approximately $69,000. OP Asset Management Ltd purchased a new stake in FIGS in the 1st quarter worth approximately $115,000. Quarry LP lifted its stake in FIGS by 1,876.3% in the 3rd quarter. Quarry LP now owns 7,846 shares of the company’s stock worth $52,000 after purchasing an additional 7,449 shares in the last quarter. Finally, May Hill Capital LLC bought a new position in FIGS in the 4th quarter valued at $117,000. 92.21% of the stock is currently owned by institutional investors.
FIGS News Roundup
Here are the key news stories impacting FIGS this week:
- Positive Sentiment: Quarterly results exceeded expectations. FIGS reported second-quarter revenue of approximately $196.6 million, up 28.8% year over year and ahead of the $186.2 million consensus estimate. Adjusted earnings were reported at $0.15 per share versus analyst expectations of $0.07 and $0.04 in the prior-year quarter. FIGS Releases Second Quarter 2026 Financial Results
- Positive Sentiment: Management raised its full-year outlook. FIGS issued 2026 revenue guidance of approximately $757.3 million, above the $729.1 million Wall Street consensus. The improved outlook signals continued demand for its healthcare apparel and supports expectations for faster growth. Figs shares jump after strong second-quarter results and higher 2026 outlook
- Positive Sentiment: Share repurchases added another support. FIGS increased its buyback authorization, potentially enhancing per-share earnings and signaling management confidence in the company’s valuation and cash-generation outlook. Figs rallies on impressive growth, upbeat outlook, and increased buyback
- Positive Sentiment: BTIG became more bullish. BTIG Research raised its price target from $20 to $22 and reiterated a “buy” rating, reflecting increased confidence in FIGS’ growth trajectory. Benzinga analyst note
- Neutral Sentiment: Analyst opinion remains mixed. Telsey Advisory Group lowered its target from $17 to $16 and kept a “market perform” rating, suggesting the recent rally may have already priced in much of the earnings improvement. The Fly analyst note
FIGS Company Profile
FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.
Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.
Featured Articles
- Five stocks we like better than FIGS
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for FIGS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FIGS and related companies with MarketBeat.com's FREE daily email newsletter.
